Verition Fund Management
ATHE

Verition Fund Management’s Alterity Therapeutics ATHE Stock Holding History

Verition Fund Management’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-881
Closed -$119K – 717
2014
Q2 		$119K Buy
+881
New +$100K 0.01% 594
2014
Q1 		– Sell
-168
Closed -$71K – 500
2013
Q4 		$71K Buy
+168
New +$50.3K 0.01% 466

Other funds holding ATHE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
CAM
Columbia Asset Management Ann Arbor, Michigan $575M AUM 29.81% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

Verition Fund Management's ATHE Position: Q3 2014 in Review

Verition Fund Management sold out of Alterity Therapeutics (ATHE) in Q3 2014, closing a stake of 881 shares — an estimated $119K sold.

Verition Fund Management first reported a position in ATHE in Q4 2013 and held it in 2 quarters. The position peaked at $119K in Q2 2014. 26 funds tracked by Wall St. Rank hold ATHE as of Q3 2014.

  • Verition Fund Management reported no remaining Alterity Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Verition Fund Management sold 881 Alterity Therapeutics shares in Q3 2014, an estimated $119K.
  • Verition Fund Management first reported a position in Alterity Therapeutics in Q4 2013 and held it in 2 quarters.
  • Verition Fund Management's Alterity Therapeutics position peaked at $119K in Q2 2014.
  • 26 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2014.

Based on Verition Fund Management's 13F filing for Q3 2014, filed 14 Nov 2014.